Action Synchrony Financial - SFE

Synchrony Financial (SFE) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

66,16

( -1,81% )

Prix Achat

65,76

Prix Vente

66,54

Volume échangé

66,94 Fourchette du Jour 67,64

0,00 Plage de 52 semaines 0,00

Clôture Veille

67,38

Ouverture

67,62

Dernière Transaction

67.64

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

MDB Capital Group Announces 'Best and Brightest' List of Qualifying Companies for 1st Annual Bright Lights Conference in San Fra

Bright Lights Conference Will Showcase 50 of the Most Innovative U.S. Small Cap Companies with Disruptive Intellectual Property in San Francisco...

Molecular Biometrics Closes $12.5 Million Series B Equity Funding

NORWOOD, Mass., Jan. 12 /PRNewswire/ -- Molecular Biometrics®, Inc., a metabolomics company developing novel clinical diagnostic tools for...

Clarient Reports 41% Revenue Increase for First Quarter 2009

New Molecular Tests and Increased Case Volume Continue to Drive Revenue Growth ALISO VIEJO, Calif., May 6 /PRNewswire-FirstCall/ -- Clarient...

Clarient Launches New Breast Cancer Test

The Clarient Insight(R) Dx Breast Cancer Profile Assists Physicians In Identifying Recurrence Risk and the Need for Chemotherapy ALISO VIEJO...

Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corpor

FOXA1 biomarker predicts likelihood of recurrence and long-term disease-free survival of breast cancer patients; Further strengthens Company's...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

SFE - Frequently Asked Questions (FAQ)

What is the current Synchrony Financial share price?

The current share price of Synchrony Financial is 66,16 €

What is the 1 year trading range for Synchrony Financial share price?

Synchrony Financial has traded in the range of 0,00 € to 0,00 € during the past year

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Synchrony Financial (SFE)

Synchrony Financial (SFE) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

SFE Dernières nouvelles

MDB Capital Group Announces 'Best and Brightest' List of Qualifying Companies for 1st Annual Bright Lights Conference in San Fra

Molecular Biometrics Closes $12.5 Million Series B Equity Funding

Clarient Reports 41% Revenue Increase for First Quarter 2009

Clarient Launches New Breast Cancer Test

Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corpor

Clarient to Present at the Cowen and Company 29th Annual Health Care Conference on Tuesday, March 17th

Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008

Laureate Pharma Appoints Gary Swan as Vice President of Operations

Laureate Pharma Extends Lease for its Facility in Princeton, NJ

EDGAR(R) Online, Inc. Announces Appointment of Philip Moyer as President

SFE - Frequently Asked Questions (FAQ)

SFE Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Synchrony Financial (SFE)

Synchrony Financial (SFE) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

SFE Dernières nouvelles

MDB Capital Group Announces 'Best and Brightest' List of Qualifying Companies for 1st Annual Bright Lights Conference in San Fra

Molecular Biometrics Closes $12.5 Million Series B Equity Funding

Clarient Reports 41% Revenue Increase for First Quarter 2009

Clarient Launches New Breast Cancer Test

Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corpor

Clarient to Present at the Cowen and Company 29th Annual Health Care Conference on Tuesday, March 17th

Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008

Laureate Pharma Appoints Gary Swan as Vice President of Operations

Laureate Pharma Extends Lease for its Facility in Princeton, NJ

EDGAR(R) Online, Inc. Announces Appointment of Philip Moyer as President

SFE - Frequently Asked Questions (FAQ)

SFE Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE